Any serious suggestions how this could be accomplished?
PPHM is currently followed by a very few analysts and is viewed and valued only as a Biotech company trying to develop an antibody to fight disease. Peregrine is evolving into Biotech plus a company with a growing CDMO business. If viewed as a value stock play, the PPS would be much higher based on Avid's contribution and projected growth. In this light, Peregrine is unique. Avid will be in front of wall street in a more aggressive manner. This is a new strategy based on growing success and market opportunity. Pretty simple, yet strategic.
News 
Market Data 
Discover 
